{'52WeekChange': 0.41879547,
 'SandP52WeekChange': None,
 'address1': '7555 Innovation Way',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 44.58,
 'askSize': 1100,
 'averageDailyVolume10Day': 248687,
 'averageVolume': 485379,
 'averageVolume10days': 248687,
 'beta': 0.814565,
 'beta3Year': None,
 'bid': 44.53,
 'bidSize': 800,
 'bookValue': 5.673,
 'category': None,
 'circulatingSupply': None,
 'city': 'Mason',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 45.02,
 'dayLow': 43.805,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -58.856,
 'enterpriseToRevenue': 7.799,
 'enterpriseValue': 1794336384,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 45.518,
 'fiftyTwoWeekHigh': 51.76,
 'fiftyTwoWeekLow': 22.57,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 38874346,
 'forwardEps': -0.95,
 'forwardPE': -46.936844,
 'fromCurrency': None,
 'fullTimeEmployees': 730,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.03214,
 'heldPercentInstitutions': 0.91966003,
 'industry': 'Medical Instruments & Supplies',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/atricure.com',
 'longBusinessSummary': 'AtriCure, Inc. develops, manufactures, and sells '
                        'devices for the surgical ablation of cardiac tissue '
                        'and systems to medical centers in the United States '
                        'and internationally. The company offers Isolator '
                        'Synergy clamps for the treatment of persistent and '
                        'long-standing persistent atrial fibrillation '
                        'concomitant to other open-heart surgical procedures; '
                        'EPi-Sense guided coagulation system used for the '
                        'coagulation of tissue; and COBRA Fusion surgical '
                        'ablation system to combine bipolar '
                        'temperature-controlled radio frequency energy control '
                        'with monopolar energy. It also provides '
                        'multifunctional pens that allow surgeons to evaluate '
                        'cardiac arrhythmias, perform temporary cardiac '
                        'pacing, sensing, and stimulation and ablate cardiac '
                        'tissue with the same device; and linear ablation '
                        'devices, which enable users to make longer linear '
                        'lines of ablation. In addition, the company offers '
                        'AtriClip system used to exclude the left atrial '
                        'appendage by mechanically clamping the appendage; '
                        'LARIAT system used to occlude the left atrial '
                        'appendage by mechanically clamping the appendage; and '
                        'cryoICE cryoablation system to apply cryo-energy to '
                        'targeted intercostal peripheral nerves in the ribcage '
                        'and temporarily relieve pain. Further, it provides '
                        'Lumitip dissector to separate tissues to provide '
                        'access to key anatomical structures that are targeted '
                        'for ablation; Fusion Magnetic Retriever System that '
                        'allows access around anatomical structures; and '
                        'cardiac surgery instruments, which are used during '
                        'surgical procedures for repair or replacement of '
                        'certain heart valves. The company sells its products '
                        'through independent distributors and direct sales '
                        'personnel. AtriCure, Inc. was founded in 2000 and is '
                        'headquartered in Mason, Ohio.',
 'longName': 'AtriCure, Inc.',
 'market': 'us_market',
 'marketCap': 1786832768,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_901985',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -45967000,
 'nextFiscalYearEnd': 1640908800,
 'open': 44.84,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -1.33,
 'phone': '513 755 4100',
 'previousClose': 44.99,
 'priceHint': 2,
 'priceToBook': 7.860039,
 'priceToSalesTrailing12Months': 7.7666097,
 'profitMargins': -0.1998,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 45.02,
 'regularMarketDayLow': 43.805,
 'regularMarketOpen': 44.84,
 'regularMarketPreviousClose': 44.99,
 'regularMarketPrice': 44.84,
 'regularMarketVolume': 218552,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 40072500,
 'sharesPercentSharesOut': 0.0326,
 'sharesShort': 1307506,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 977891,
 'shortName': 'AtriCure, Inc.',
 'shortPercentOfFloat': 0.04,
 'shortRatio': 3.46,
 'startDate': None,
 'state': 'OH',
 'strikePrice': None,
 'symbol': 'ATRC',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.209,
 'twoHundredDayAverage': 40.558056,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '03c18d5f-d166-3e68-a33f-118b1b088dc1',
 'volume': 218552,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.atricure.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '45040'}